marijuana stocks news

Cannabis Sativa, Inc. (CBDS)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014
Total Revenue 1   4   1   0  
Cost of Revenue 1 0 0 1
Gross Profit (0) 4   1   (1)
Operating Expenses
Research Development – 4 – –
Selling General and Administrative 1,780 987 171 100
Non Recurring – 13,070 – –
Others – – – –
Total Operating Expenses – – – –
Operating Income or Loss (1,780) (14,057) (170) (101)
Income from Continuing Operations
Total Other Income/Expenses Net – 90 (40) –
Earnings Before Interest And Taxes (1,780) (13,968) (210) (101)
Interest Expense 8 8 6 4
Income Before Tax (1,788) (13,975) (216) (104)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (1,788) (13,975) (216) (104)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (1,788) (13,975) (216) (104)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (1,788) (13,975) (216) (104)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GT Biopharma Inc. (GTBP) Announces Stock Sales Agreement with Holders of Converted Securities

GT Biopharma Announces Stock Sales Agreement with Holders of Converted Securities GT…

$MCIG Announces New Industry Awards

mCig Announces Ultimate Cannabis Innovation Awards. First-of-Its-Kind Event Gives Entrepreneurs Access to…

$GWPH Announces New Planned Epidiolex Development Program

GW Pharmaceuticals Announces New Planned Epidiolex (Cannabidiol or CBD) Development Program in…